Next Article in Journal
TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
Next Article in Special Issue
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Previous Article in Journal
Acknowledgement to Reviewers of Antibodies in 2014
Previous Article in Special Issue
Antibody Fragments Defining Biologically Relevant Conformations of Target Proteins
Article Menu

Export Article

Open AccessReview
Antibodies 2015, 4(1), 12-33; doi:10.3390/antib4010012

Cell-Free Synthesis Meets Antibody Production: A Review

Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses Potsdam-Golm (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany
*
Author to whom correspondence should be addressed.
Academic Editor: Satoshi Ohtake
Received: 2 December 2014 / Accepted: 13 January 2015 / Published: 26 January 2015
(This article belongs to the Special Issue Antibody Constructs)
View Full-Text   |   Download PDF [1525 KB, uploaded 26 January 2015]   |  

Abstract

Engineered antibodies are key players in therapy, diagnostics and research. In addition to full size immunoglobulin gamma (IgG) molecules, smaller formats of recombinant antibodies, such as single-chain variable fragments (scFv) and antigen binding fragments (Fab), have emerged as promising alternatives since they possess different advantageous properties. Cell-based production technologies of antibodies and antibody fragments are well-established, allowing researchers to design and manufacture highly specific molecular recognition tools. However, as these technologies are accompanied by the drawbacks of being rather time-consuming and cost-intensive, efficient and powerful cell-free protein synthesis systems have been developed over the last decade as alternatives. So far, prokaryotic cell-free systems have been the focus of interest. Recently, eukaryotic in vitro translation systems have enriched the antibody production pipeline, as these systems are able to mimic the natural pathway of antibody synthesis in eukaryotic cells. This review aims to overview and summarize the advances made in the production of antibodies and antibody fragments in cell-free systems. View Full-Text
Keywords: cell-free; cell-free protein synthesis; antibody; antibody fragment; scFv; disulfide bond formation; microsomal vesicles; eukaryotic lysate cell-free; cell-free protein synthesis; antibody; antibody fragment; scFv; disulfide bond formation; microsomal vesicles; eukaryotic lysate
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Stech, M.; Kubick, S. Cell-Free Synthesis Meets Antibody Production: A Review. Antibodies 2015, 4, 12-33.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top